To investigate effects of prolonged dopaminergic antagonism on LH pulsatile secretion, 22 normal cycling women (10 in the early follicular phase (days 3 and 4), 6 in the late follicular phase (days 10 to 13), 6 in the midluteal phase (days 6 to 8 after ovulations)) and 8 postmenopausal women were studied before and during 8-h dopamine receptor blockade imposed by metoclopramide. Sequential 8-h infusions of either saline (50 ml/ h) or metoclopramide (30 \ g=m\ g \ m=. \ kg\m=-\1 \ m=. \ h\m=-\1) were conducted on two consecutive days. LH pulsatile activity was assessed in blood samples obtained at 15 min intervals during these 8-h infusion periods. Basal estradiol and progesterone concentrations were lowest (p <0.001) in postmenopausal and highest (p <0.001) in the midluteal phase women, 8-h metoclopramide infusions evoked prompt (within 90 min, p <0.001) and sustained (> 70 \ g=m\ g/ 1, p < 0.001) increases of PRL, similar (p = 0.78)) in magnitude for normal cycling and postmenopausal women. Metoclopramide infusions failed to significantly modify the LH pulsatile acitivity during the menstrual cycles and in hypogonadal women. These observations suggest that even in the presence of high circulating estradiol and progesterone concentrations the dopaminergic inhibition may not be operating. However, any possible stimulatory effect on LH secretion by dopamine receptor blockade may be confounded by the concomitant metoclopramide-induced hyperprolactinemia.The role of dopamine (DA) in the regulation of GnRH-LH secretion remains controversial. The administrations of DA and its agonists consistently inhibit LH secretion in women during all phases of the menstrual cycle (1-3). This inhibitory effect of DA becomes most pronounced during periods of high serum estrogen and estrogen-progesterone concentrations, as observed in the late follicular and luteal phases of the cycle. Conversely, experi¬ ments using short-term DA receptor blockade im¬ posed by intravenous injections of DA receptor blockers have demonstrated that acute DA anta¬ gonism does not alter the serum gonadotropin le¬ vels in women during the menstrual cycle (4-6). Consequently, the endogenous DA inhibition of GnRH-LH secretion may not be activated during the normal menstrual cycle, even though DA infu¬ sions inhibit GnRH-LH secretion, most evident in the follicular and luteal phases. Thus, the relative contribution of the dopaminergic system to the neuroendocrine control of GnRH-LH release re¬ mains to be defined.Previous studies investigating the DA regulation of GnRH-LH secretion have utilized a short-term DA antagonism by means of intravenous bolus in¬ jections of DA blockers, such as metoclopramide. However, any DA regulation of the episodic LH re¬ lease and its possible dependency from the circu¬ lating serum sex steroid concentrations can only be estimated by a more prolonged DA blockade. Accordingly, we studied the LH pulsatile activity in eugonadal women during their normal cycles and in hypogonadal women after the natural meno¬ pause before and duri...